Achieving optimal bone health in cystic fibrosis: ready for prime time?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Therapy

• Publication date

  2011-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/THY.11.78
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D(3) is more potent than vitamin D(2) in humans.

  2011cited by this paper
• The 2011 Report on Dietary Reference Intake for Vitamin D: Where Do We Go From Here?

  2011cited by this paper
• Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis.

  2011cited by this paper
• Vitamins as drugs: the importance of pharmacokinetics in oral dosing

  2011cited by this paper
• Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

  2011cited by this paper
• European cystic fibrosis bone mineralisation guidelines.

  2011cited by this paper
• Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

  2011cited by this paper
• Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis

  2011cited by this paper
• Approach to the child with fractures.

  2011cited by this paper
• Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients.

  2010cited by this paper
• Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.

  2009cited by this paper
• Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study

  2009cited by this paper
• Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.

  2009cited by this paper
• Vitamin D in infants with cystic fibrosis diagnosed by newborn screening

  2009cited by this paper
• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  2009cited by this paper
• Bone mineral density in cystic fibrosis patients under the age of 18 years.

  2008cited by this paper
• Does treatment with bisphosphonates endanger the human pregnancy?

  2008cited by this paper
• Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.

  2005cited by this paper
• Consensus statement: Guide to bone health and disease in cystic fibrosis

  2005cited by this paper
• Efficacité des biphosphonates oraux sur la déminéralisation osseuse des patients atteints de mucoviscidose

  2004cited by this paper
• Altered Calcium Homeostasis in Adults with Cystic Fibrosis

  1999cited by this paper
• Prevalence of Vitamin D Insufficiency in an Adult Normal Population

  1997cited by this paper

• No citing papers are available for this paper.